Lovaza Manufacturer to Enter Consumer Healthcare Market
Pronova BioPharma (Lysaker, Norway) says it will enter the consumer healthcare market during the second half of 2012.
Answering to rising consumer interest in omega-3 products, Pronova BioPharma (Lysaker, Norway) says it will enter the consumer healthcare market during the second half of 2012. The company currently markets Omacor/Lovaza, the only omega-3 pharmaceutical drug approved for use by FDA and the EU.
Over the next 12 months, Pronova plans to build its consumer healthcare division by initiating clinical trials, adjusting manufacturing its manufacturing process for consumer products, and developing distribution channels.
Continuing innovation in algae-DHA: Natural Products Expo West 2024 Report
March 26th 2024At this year’s Natural Products Expo West, two brands have launched their own versions of algae DHA ingredients; FrieslandCampina and Aker BioMarine. Each brand showcased a different approach to the ingredient.
